Bone response of TGF-β2 immobilized titanium in a rat model

Dental Materials Journal

Volumn 33, Issue 2, 2014, Pages 233-241

  Suzuki, Takuma ^a   Hayakawa, Tohru ^a   Kawamoto, Tadafumi ^a   Gomi, Kazuhiro ^a  

^a TSURUMI UNIVERSITY   (Japan)

Author keywords

Immobilization; TGF 2; Titanium; Tresyl chloride

Indexed keywords

ATOMIC FORCE MICROSCOPY; BONE; CHLORINE COMPOUNDS; DEFECTS; INFRARED IMAGING; RADIOACTIVE WASTE VITRIFICATION; RATS; SURFACE ROUGHNESS;

BONE FORMATION; BONE REGENERATION; BONE RESPONSE; BONE-TO-IMPLANT CONTACT; HISTOLOGICAL OBSERVATIONS; MEASUREMENTS OF; TITANIUM IMPLANTS; TRESYL CHLORIDE;

TITANIUM;

TITANIUM; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ANIMAL MODEL; BONE; MALE; PHYSIOLOGY; RAT; SURFACE PROPERTY; WISTAR RAT;

ANIMALS; BONE AND BONES; MALE; MODELS, ANIMAL; RATS; RATS, WISTAR; SURFACE PROPERTIES; TITANIUM; TRANSFORMING GROWTH FACTOR BETA;

EID: 84897060361     PISSN: 02874547     EISSN: 18811361     Source Type: Journal    
DOI: 10.4012/dmj.2014-006     Document Type: Article

References (44)

1. Albrektsson T, Brånemark PI, Hansson HA, Lindström J. Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop Scand 1981; 52: 155-170.
2. Adell R. Tissue integrated prostheses in clinical dentistry. Int Dent J 1985; 35: 259-265.
3. Nishio K, Neo M, Akiyama H, Nishiguchi S, Kim HM, Kokubo T, Nakamura T. The effect of alkali-and heat-treated titanium and apatite-formed titanium on osteoblastic differentiation of bone marrow cells. J Biomed Mater Res 2000; 52: 652-661.
4. Buser D, Broggini N, Wieland M, Schenk RK, Denzer AJ, Cochran DL, Hoffmann B, Lussi A, Steinemann SG. Enhanced bone apposition to a chemically modified SLA titanium surface. J Dent Res 2004; 83: 529-533.
5. Bagno A, Di Bello C. Surface treatments and roughness properties of Ti-based biomaterials. J Mater Sci Mater Med 2004; 15: 935-949.
6. Junker R, Dimakis A, Thoneick M, Jansen JA. Effect of implant surface coating and composition on bone integration: a systematic review. Clin Oral Implant Res 2009; 20: 185-206.
7. El-Ghannam A, Starr L, Jones J. Laminin-5 coating enhances epithelial cell attachment, spreading, and hemidesmosome assembly on Ti-6Al-4V implant material in vitro. J Biomed Mater Res 1998; 41: 30-40.
8. Beutner R, Michael J, Schwenzer B, Scharnweber D. Biological nano-functionalization of titanium-based biomaterial surfaces: a flexible toolbox. J R Soc Interface 2010; 7: 93-105.
9. Bhola R, Su F, Krull CE. Functionalization of titanium based metallic biomaterials for implant applications. J Mater Sci Mater Med 2011; 22: 1147-1159.
10. Rapuano BE, Hackshaw KM, Schniepp HC, MacDonald DE. Effects of coating a titanium alloy with fibronectin on the expression of osteoblast gene markers in the MC3T3 osteoprogenitor cell line. Int J Oral Maxillofac Implants 2012; 27: 1081-1090.
11. Hayakawa T, Yoshinari M, Nemoto K. Direct attachment of fibronectin of fibronectin to tresyl chroride activated titanium. J Biomed Mater Res A 2003; 67A: 684-688.
12. Hayakawa T, Yoshinari M, Nagai M, Yamamoto M, Nemoto K. X-ray photoelectron spectroscopic studies of the reactivity of basic terminal OH of titanium towards tresyl chloride and fibronectin. Biomed Res 2003; 24: 223-230.
13. Nilsson K, Mosbach K. Tresyl chloride-activated supports for enzyme immobilization. Methods Enzymol 1987; 135: 65-78.
14. Boehm HP. Acidic and basic properties of hydroxylated metal oxide surface. Faraday Discuss Faraday Soc 1971; 52: 264-275.
15. Hayakawa T, Yoshinari M, Nemoto K. Quartz-crystal microbalance-dissipation technique for the study of initial adsorption of fibronectin onto tresyl chloride-activated titanium. J Biomed Mater Res B Appl Biomater 2005; 73B: 271-276.
16. Pugdee K, Shibata Y, Yamamichi N, Tsutsumi H, Yoshinari M, Abiko Y, Hayakawa T. Gene expression of MC3T3-E1 cells on fibronectin immobilized titanium using tresyl chlorideactivation technique. Dent Mater J 2007; 26: 647-655.
17. Yamamichi N, Pugdee K, Chang W, Lee S, Yoshinari M, Hayakawa T, Abiko Y. Gene expression monitoring in osteoblasts on fibronectin derived peptide coated titanium. Dent Mater J 2008; 27: 744-750.
18. Yoshida E, Yoshimura Y, Uo M, Yoshinari M, Hayakawa T. Influence of nanometer smoothness and fibronectin immobilization of titanium surface on MC3T3-E1 cell behavior. J Biomed Mater Res Part A 2012; 100A: 1556-1564.
19. Ferraris S, Spriano S, Bianchi CL, Cassinelli C, Vernè E. Surface modification of Ti-6Al-4 V alloy for biomineralization and specific biological response: part II, alkaline phosphatase grafting. J Mater Sci Mater Med 2011; 22: 1835-1842.
20. Babensee JE, McIntire LV, Mikos AG. Growth factor delivery for tissue engineering. Pharm Res 2000; 17: 497-504.
21. Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 2002; 84-A: 1032-1044.
22. Chang H, Brown CW, Matzuk MM. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 2002; 23: 787-823.
23. Lind M, Schumacker B, Søballe K, Keller J, Melsen F, Bünger C. Transforming growth factor-β enhances fracture healing in rabbit tibiae. Acta Orthop Scand 1993; 64: 553-556.
24. Nielsen HM, Andreassen TT, Ledet T, Oxlund H. Local injection of TGF-β increases the strength of tibial fractures in the rat. Acta Orthop Scand 1994; 65: 37-41.
25. De Ranieri A, Virdi AS, Kuroda S, Shott S, Leven RM, Hallab NJ, Sumner DR. Local application of rhTGF-beta2 enhances peri-implant bone volume and bone-implant contact in a rat model. Bone 2005; 37: 55-62.
26. Sena K, Sumner DR, Virdi AS. Effect of recombinant human transforming growth factor-beta2 dose on bone formation in rat femur titanium implant model. J Biomed Mater Res A 2010; 92: 1210-1217.
27. Sumner DR, Turner TM, Urban RM, Virdi AS, Inoue N. Additive enhancement of implant fixation following combined treatment with rhTGF-beta2 and rhBMP-2 in a canine model. J Bone Joint Surg Am 2006; 88: 806-817.
28. Donath K, Breuner G. A method for the study of undecalcified bones and teeth with attached soft tissues. The Säge-Schliff (sawing and grinding) technique. J Oral Pathol 1982; 11: 318-326.
29. Endo K. Chemical modification of metallic implant surfaces with biofunctional proteins (Part 1). Molecular structure and biological activity of a modified NiTi alloy surface. Dent Mater J 1995; 14: 185-198.
30. Nanci A, Wuest JD, Peru L, Brunet P, Sharma V, Zalzal S, McKee MD. Chemical modification of titanium surfaces for covalent attachment of biological molecules. J Biomed Mater Res 1998; 40: 324-335.
31. Cacchioli A, Ravanetti F, Bagno A, Dettin M, Gabbi C. Human vitronectin-derived peptide covalently grafted onto titanium surface improves osteogenic ativity: A pilot in vivo study on rabbits. Tissue Eng Part A 2009; 15: 2917-2926.
32. Dettin M, Herath T, Gambaretto R, Iucci G, Battocchio C, Bagno A, Ghezzo F, Di Bello C, Polzonetti G, Di Silvio L. Assessment of novel chemical strategies for covalent attachment of adhesive peptides to rough titanium surfaces: XPS analysis and biological evaluation. J Biomed Mater Res A 2009; 91: 463-479.
33. Qui X, Gysin R, Mohan S, Baylink DJ. Bone growth factors. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. 2nd ed. San Diego: Academic Press; 2001. p. 405-431.
34. Moioli EK, Clark PA, Sumner DR, Mao JJ. Autologous stem cell regeneration in craniosynostosis. Bone 2008; 42: 332-340.
35. Joyce ME, Roberts AB, Sporn MB, Bolander ME. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 1990; 110: 2195-2207.
36. Marcelli C, Yates AJ, Mundy GR. In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice. J Bone Miner Res 1990; 5: 1087-1096.
37. Fujimoto R, Tanizawa T, Nishida S, Yamamoto N, Soshi S, Endo N, Takahashi HE. Local effects of transforming growth factor-beta1 on rat calvaria: changes depending on the dose and the injection site. J Bone Miner Metab 1999; 17: 11-17.
38. Rosen D, Miller SC, DeLeon E, Thompson AY, Bentz H, Mathews M, Adams S. Systemic administration of recombinant transforming growth factor beta 2 (rTGF-beta 2. stimulates parameters of cancellous bone formation in juvenile and adult rats. Bone 1994; 15: 355-359.
39. Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Ghosh-Choudhury N, Wozney J, Mundy GR. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 1994; 9: 855-863.
40. Chen TL, Bates RL. Recombinant human transforming growth factor beta 1 modulates bone remodeling in a mineralizing bone organ culture. J Bone Miner Res 1993; 8: 423-434.
41. Mundy GR, Oyajobi B, Traianedes K, Dallas S, Chen D. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. 2nd ed. San Diego: Academic Press; 2001. p. 373-403.
42. Daopin S, Piez KA, Ogawa Y, Davies DR. Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily. Science 1992; 257: 369-373.
43. Hayashi M, Jimbo R, Xue Y, Mustafa K, Andersson M, Wennerberg A. Photocatalytically induced hydrophilicity influences bone remodelling at longer healing periods: a rabbit study. Clin Oral Implants Res 2013 Feb 26. doi: 10.1111/clr.12138 [Epub ahead of print].
44. Iyama S, Takeshita F, Ayukawa Y, Kido MA, Suetsugu T, Tanaka T. A study of the regional distribution of bone formed around hydroxyapatite implants in the tibiae of streptozotocininduced diabetic rats using multiple fluorescent labeling and confocal laser scanning microscopy. J Periodontol 1997; 68: 1169-1175.